Mimicking maternal smoking and pharmacotherapy of preterm labor: Interactions of fetal nicotine and dexamethasone on serotonin and dopamine synaptic function in adolescence and adulthood

Brain Research Bulletin

Volumn 82, Issue 1-2, 2010, Pages 124-134

  Slotkin, Theodore A ^a   Seidler, Frederic J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain development; Dexamethasone; Dopamine; Glucocorticoids; Nicotine; Preterm delivery; Serotonin

Indexed keywords

DEXAMETHASONE; DOPAMINE RECEPTOR; GLUCOCORTICOID; NEUROTRANSMITTER; NICOTINE; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER;

ADOLESCENCE; ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; COGNITION; CONSENSUS; CONTROLLED STUDY; FEMALE; GESTATION PERIOD; MALE; MATERNAL SMOKING; NERVE CELL LESION; NONHUMAN; PERIKARYON; PREMATURE LABOR; PREMATURITY; PRENATAL EXPOSURE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROGENY; RAT; RECEPTOR UPREGULATION; SYNAPSE; TERATOGENESIS;

ADOLESCENT; ADULT; ANIMALS; DEXAMETHASONE; DOPAMINE; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MATERNAL EXPOSURE; NICOTINE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGENTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SMOKING; SYNAPSES;

EID: 77952320564     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2010.02.015     Document Type: Article

References (79)

1. Abreu-Villaça Y., Seidler F.J., Tate C.A., Cousins M.M., Slotkin T.A. Prenatal nicotine exposure alters the response to nicotine administration in adolescence: effects on cholinergic systems during exposure and withdrawal. Neuropsychopharmacology 2004, 29:879-890.
2. Aldridge J.E., Levin E.D., Seidler F.J., Slotkin T.A. Developmental exposure of rats to chlorpyrifos leads to behavioral alterations in adulthood, involving serotonergic mechanisms and resembling animal models of depression. Environ. Health Perspect. 2005, 113:527-531.
3. Aldridge J.E., Seidler F.J., Slotkin T.A. Developmental exposure to chlorpyrifos elicits sex-selective alterations of serotonergic synaptic function in adulthood: critical periods and regional selectivity for effects on the serotonin transporter, receptor subtypes, and cell signaling. Environ. Health Perspect. 2004, 112:148-155.
4. Anisman H., Zaharia M.D., Meaney M.J., Merali Z. Do early-life events permanently alter behavioral and hormonal responses to stressors?. Int. J. Dev. Neurosci. 1998, 16:149-164.
5. Arango V., Underwood M.D., Boldrini M., Tamir H., Kassir S.A., Hsiung S., Chen J.J., Mann J.J. Serotonin-1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 2001, 25:892-903.
6. Bakker J.M., van Bel F., Heijnen C.J. Neonatal glucocorticoids and the developing brain: short-term treatment with life-long consequences?. Trends Neurosci. 2001, 24:649-653.
7. Barrington K.J. The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr. 2001, 1:1-9.
8. Belluardo N., Mudo G., Blum M., Fuxe K. Central nicotinic receptors, neurotrophic factors and neuroprotection. Behav. Brain Res. 2000, 113:21-34.
9. Bhuta T., Ohlsson A. Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease. Arch. Dis. Child. 1998, 79:F26-F33.
10. Burguet A., Kaminski M., Truffert P., Menget A., Marpeau L., Voyer M., Roze J.C., Escande B., Cambonie G., Hascoet J.M., Grandjean H., Breart G., Larroque B., G.Epipage Study Does smoking in pregnancy modify the impact of antenatal steroids on neonatal respiratory distress syndrome? Results of the Epipage study. Arch. Dis. Child. 2005, 90:F41-F45.
11. Cavalieri R.L., Cohen W.R. Antenatal steroid therapy: have we undervalued the risks?. J. Matern. Fetal Neonat. Med. 2006, 19:265-269.
12. Coe C.L., Lubach G.R. Developmental consequences of antenatal dexamethasone treatment in nonhuman primates. Neurosci. Biobehav. Rev. 2005, 29:227-235.
13. Dammann O., Matthews S.G. Repeated antenatal glucocorticoid exposure and the developing brain. Pediatr. Res. 2001, 50:563-564.
14. Dwyer J.B., Broide R.S., Leslie F.M. Nicotine and brain development. Birth Defects Res. C 2008, 84:30-44.
15. Ernst M., Moolchan E.T., Robinson M.L. Behavioral and neural consequences of prenatal exposure to nicotine. J. Am. Acad. Child Adolesc. Psychiat. 2001, 40:630-641.
16. Fewell J.E., Smith F.G., Ng V.K.Y. Threshold levels of maternal nicotine impairing protective responses of newborn rats to intermittent hypoxia. J. Appl. Physiol. 2001, 90:1968-1976.
17. Fujita M., Charney D.S., Innis R.B. Imaging serotonergic neurotransmission in depression: hippocampal pathophysiology may mirror global brain alterations. Biol. Psychiat. 2000, 48:801-812.
18. Gilstrap L.C., Christensen R., Clewell W.H., D'Alton M.E., Davidson E.C., Escobedo M.B., Gjerdingen D.K., Goddard-Finegold J., Goldenberg R.L., Grimes D.A., Hansen T.N., Kauffman R.E., Keeler E.B., Oh W., Susman E.J., Vogel M.G., Avery M.E., Ballard R.A., Crowley P., Garite T., Hankins G.D.V., Jobe A.H., Koppe J.G., Maher J.E., Merkatz I.R., Shankaran S., Simpson K.N., Sinclair J.C., Slotkin T.A., Taeusch H.W., Wright L.L. Effect of corticosteroids for fetal maturation on perinatal outcomes. J. Am. Med. Assoc. 1995, 273:413-418.
19. Herrmann M., King K., Weitzman M. Prenatal tobacco smoke and postnatal secondhand smoke exposure and child neurodevelopment. Curr. Opin. Pediatr. 2008, 20:184-190.
20. Hohmann C.F. A morphogenetic role for acetylcholine in mouse cerebral neocortex. Neurosci. Biobehav. Rev. 2003, 27:351-363.
21. Isaac P.F., Rand M.J. Cigarette smoking and plasma levels of nicotine. Nature 1972, 236:308-310.
22. Kreider M.L., Aldridge J.E., Cousins M.M., Oliver C.A., Seidler F.J., Slotkin T.A. Disruption of rat forebrain development by glucocorticoids: critical perinatal periods for effects on neural cell acquisition and on cell signaling cascades mediating noradrenergic and cholinergic neurotransmitter/neurotrophic responses. Neuropsychopharmacology 2005, 30:1841-1855.
23. Kreider M.L., Tate C.A., Cousins M.M., Oliver C.A., Seidler F.J., Slotkin T.A. Lasting effects of developmental dexamethasone treatment on neural cell number and size, synaptic activity and cell signaling: critical periods of vulnerability, dose-effect relationships, regional targets and sex selectivity. Neuropsychopharmacology 2006, 31:12-35.
24. Lauder J.M., Schambra U.B. Morphogenetic roles of acetylcholine. Environ. Health Perspect. 1999, 107(Suppl. 1):65-69.
25. Levin E.D., Addy N., Baruah A., Elias A., Christopher N.C., Seidler F.J., Slotkin T.A. Prenatal chlorpyrifos exposure in rats causes persistent behavioral alterations. Neurotoxicol. Teratol. 2002, 24:733-741.
26. Levin E.D., Slotkin T.A. Developmental neurotoxicity of nicotine. Handbook of Developmental Neurotoxicology 1998, 587-615. Academic Press, San Diego. W. Slikker, L.W. Chang (Eds.).
27. Lichtensteiger W., Ribary U., Schlumpf M., Odermatt B., Widmer H.R. Prenatal adverse effects of nicotine on the developing brain. Prog. Brain Res. 1988, 73:137-157.
28. Maccari S., Darnaudery M., Morley-Fletcher S., Zuena A.R., Cinque C., Van Reeth O. Prenatal stress and long-term consequences: implications of glucocorticoid hormones. Neurosci. Biobehav. Rev. 2003, 27:119-127.
29. Maes M., Meltzer H. The serotonin hypothesis of major depression. Psychopharmacology: The Fourth Generation of Progress 1995, 933-944. Raven Press, New York. F.E. Bloom, D.J. Kupfer, B.S. Bunney, R.D. Ciaranello, K.L. Davis, G.F. Koob, H.Y. Meltzer, C.R. Schuster, R.I. Shader, S.J. Watson (Eds.).
30. Mainous A.G., Hueston W.J. The effect of smoking cessation during pregnancy on preterm delivery and low birthweight. J. Fam. Pract. 1994, 38:262-266.
31. Matthews S.G. Antenatal glucocorticoids and programming of the developing CNS. Pediatr. Res. 2000, 47:291-300.
32. McGrath K.E., Seidler F.J., Slotkin T.A. Convergent control of serotonin transporter expression by glucocorticoids and cocaine in fetal and neonatal rat brain. Dev. Brain Res. 1997, 104:209-213.
33. Meyer A., Seidler F.J., Aldridge J.E., Slotkin T.A. Developmental exposure to terbutaline alters cell signaling in mature rat brain regions and augments the effects of subsequent neonatal exposure to the organophosphorus insecticide, chlorpyrifos. Toxicol. Appl. Pharmacol. 2005, 203:154-166.
34. Moritz K.M., Boon W.M., Wintour E.M. Glucocorticoid programming of adult disease. Cell Tissue Res. 2005, 322:81-88.
35. Murrin L.C., Ferrer J.R., Wanyun Z., Haley N.J. Nicotine administration to rats: methodological considerations. Life Sci. 1987, 40:1699-1708.
36. Murrin L.C., Ferrer J.R., Zeng W. Nicotine administration during pregnancy and its effect on striatal development. Neurosci. Abs. 1985, 11:69.
37. Nemeroff C.B. The neurobiology of depression. Sci. Am. 1998, 278(6):42-49.
38. Newnham J.P. Is prenatal glucocorticoid administration another origin of adult disease?. Clin. Exp. Pharmacol. Physiol. 2001, 28:957-961.
39. Nutt D.J. The neuropharmacology of serotonin and noradrenaline in depression. Int. Clin. Psychopharmacol. 2002, 17:S1-S12.
40. Owen D., Andrews M.H., Matthews S.G. Maternal adversity, glucocorticoids and programming of neuroendocrine function and behaviour. Neurosci. Biobehav. Rev. 2005, 29:209-226.
41. Pauly J.R., Slotkin T.A. Maternal tobacco smoking, nicotine replacement and neurobehavioural development. Acta Pædiatr. 2008, 97:1331-1337.
42. Peacock J.L., Bland J.M., Anderson H.R. Preterm delivery: effects of socioeconomic factors, psychological stress, smoking, alcohol, and caffeine. BMJ 1995, 311:531-535.
43. Raff H. Neonatal dexamethasone therapy: short- and long-term consequences. Trends Endocrinol. Metab. 2004, 15:351-352.
44. Rhodes M.C., Seidler F.J., Qiao D., Tate C.A., Cousins M.M., Slotkin T.A. Does pharmacotherapy for preterm labor sensitize the developing brain to environmental neurotoxicants? Cellular and synaptic effects of sequential exposure to terbutaline and chlorpyrifos in neonatal rats. Toxicol. Appl. Pharmacol. 2004, 195:203-217.
45. Ribary U., Lichtensteiger W. Effects of acute and chronic prenatal nicotine treatment on central catecholamine systems of male and female rat fetuses and offspring. J. Pharmacol. Exp. Ther. 1989, 248:786-792.
46. Seckl J.R. Glucocorticoid programming of the fetus: adult phenotypes and molecular mechanisms. Mol. Cell. Endocrinol. 2001, 185:61-71.
47. Seckl J.R. Prenatal glucocorticoids and long-term programming. Eur. J. Endocrinol. 2004, 151:U49-U62.
48. Sekhon H.S., Jia Y.B., Raab R., Kuryatov A., Pankow J.F., Whitsett J.A., Lindstrom J., Spindel E.R. Prenatal nicotine increases pulmonary α7 nicotinic receptor expression and alters fetal lung development in monkeys. J. Clin. Invest. 1999, 103:637-647.
49. Sholl J.S. Abruptio placentae: clinical management in nonacute cases. Am. J. Obstet. Gynecol. 1987, 156:40-51.
50. Slotkin T.A. Prenatal exposure to nicotine: what can we learn from animal models?. Maternal Substance Abuse and the Developing Nervous System 1992, 97-124. Academic Press, San Diego. I.S. Zagon, T.A. Slotkin (Eds.).
51. Slotkin T.A. Fetal nicotine or cocaine exposure: which one is worse?. J. Pharmacol. Exp. Ther. 1998, 285:931-945.
52. Slotkin T.A. Developmental cholinotoxicants: nicotine and chlorpyrifos. Environ. Health Perspect. 1999, 107(Suppl. 1):71-80.
53. Slotkin T.A. Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol. Appl. Pharmacol. 2004, 198:132-151.
54. Slotkin T.A. If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents?. Neurotoxicol. Teratol. 2008, 30:1-19.
55. Slotkin T.A., Barnes G.A., McCook E.C., Seidler F.J. Programming of brainstem serotonin transporter development by prenatal glucocorticoids. Dev. Brain Res. 1996, 93:155-161.
56. Slotkin T.A., Kreider M.L., Tate C.A., Seidler F.J. Critical prenatal and postnatal periods for persistent effects of dexamethasone on serotonergic and dopaminergic systems. Neuropsychopharmacology 2006, 31:904-911.
57. Slotkin T.A., Levin E.D., Seidler F.J. Comparative developmental neurotoxicity of organophosphate insecticides: effects on brain development are separable from systemic toxicity. Environ. Health Perspect. 2006, 114:746-751.
58. Slotkin T.A., MacKillop E.A., Rudder C.L., Ryde I.T., Tate C.A., Seidler F.J. Permanent, sex-selective effects of prenatal or adolescent nicotine exposure, separately or sequentially, in rat brain regions: indices of cholinergic and serotonergic synaptic function, cell signaling, and neural cell number and size at six months of age. Neuropsychopharmacology 2007, 32:1082-1097.
59. Slotkin T.A., Ryde I.T., Seidler F.J. Separate or sequential exposure to nicotine prenatally and in adulthood: persistent effects on acetylcholine systems in rat brain regions. Brain Res. Bull. 2007, 74:91-103.
60. Slotkin T.A., Ryde I.T., Seidler F.J. Additive and synergistic effects of fetal nicotine and dexamethasone exposure on cholinergic synaptic function in adolescence and adulthood: implications for the adverse consequences of maternal smoking and pharmacotherapy of preterm delivery. Brain Res. Bull. 2010, 81:552-560.
61. Slotkin T.A., Ryde I.T., Tate C.A., Seidler F.J. Lasting effects of nicotine treatment and withdrawal on serotonergic systems and cell signaling in rat brain regions: separate or sequential exposure during fetal development and adulthood. Brain Res. Bull. 2007, 73:259-272.
62. Slotkin T.A., Seidler F.J. The alterations in CNS serotonergic mechanisms caused by neonatal chlorpyrifos exposure are permanent. Dev. Brain Res. 2005, 158:115-119.
63. Slotkin T.A., Seidler F.J. Developmental exposure to terbutaline and chlorpyrifos, separately or sequentially, elicits presynaptic serotonergic hyperactivity in juvenile and adolescent rats. Brain Res. Bull. 2007, 73:301-309.
64. Slotkin T.A., Seidler F.J. Prenatal chlorpyrifos exposure elicits presynaptic serotonergic and dopaminergic hyperactivity at adolescence: critical periods for regional and sex-selective effects. Reprod. Toxicol. 2007, 23:421-427.
65. Slotkin T.A., Seidler F.J., Ali S.F. Cellular determinants of reduced adaptability of the aging brain: neurotransmitter utilization and cell signaling responses after MDMA lesions. Brain Res. 2000, 879:163-173.
66. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150:76-85.
67. Snedecor G.W., Cochran W.G. Statistical Methods 1967, Iowa State University Press, Ames, Iowa.
68. Steingart R.A., Abou-Roumi M., Newman M.E., Silverman W.F., Slotkin T.A., Yanai J. Neurobehavioral damage to cholinergic systems caused by prenatal exposure to heroin or phenobarbital: cellular mechanisms and the reversal of deficits by neural grafting. Dev. Brain Res. 2000, 122:125-133.
69. Takahashi L.K. Prenatal stress: consequences of glucocorticoids on hippocampal development and function. Int. J. Dev. Neurosci. 1998, 16:199-207.
70. Timofeeva O.A., Roegge C.S., Seidler F.J., Slotkin T.A., Levin E.D. Persistent cognitive alterations in rats after early postnatal exposure to low doses of the organophosphate pesticide, diazinon. Neurotoxicol. Teratol. 2008, 30:38-45.
71. Trauth J.A., Seidler F.J., Slotkin T.A. An animal model of adolescent nicotine exposure: effects on gene expression and macromolecular constituents in rat brain regions. Brain Res. 2000, 867:29-39.
72. Vatury O., Barg J., Slotkin T.A., Yanai J. Altered localization of choline transporter sites in the mouse hippocampus after prenatal heroin exposure. Brain Res. Bull. 2004, 53:25-32.
73. Weinstock M. Alterations induced by gestational stress in brain morphology and behaviour of the offspring. Prog. Neurobiol. 2001, 65:427-451.
74. White E., Shy K.K., Daling J.R., Guthrie R.D. Maternal smoking and infant respiratory distress syndrome. Obstet. Gynecol. 1986, 67:365-370.
75. Whitelaw A., Thoresen M. Antenatal steroids and the developing brain. Arch. Dis. Child. 2000, 83:F154-F157.
76. Wisborg K., Henriksen T.B. Is smoking during pregnancy a cause of premature delivery?. Ugeskrift for Laeger 1995, 157:6707-6712.
77. Xu Z., Seidler F.J., Ali S.F., Slikker W., Slotkin T.A. Fetal and adolescent nicotine administration: effects on CNS serotonergic systems. Brain Res. 2001, 914:166-178.
78. Yatham L.N., Liddle P.F., Dennie J., Shiah I.S., Adam M.J., Lane C.J., Lam R.W., Ruth T.J. Decrease in brain serotonin-2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone. Arch. Gen. Psychiat. 1999, 56:705-711.
79. Yatham L.N., Liddle P.F., Shiah I.S., Scarrow G., Lam R.W., Adam M.J., Zis A.P., Ruth T.J. Brain serotonin-2 receptors in major depression: a positron emission tomography study. Arch. Gen. Psychiat. 2000, 57:850-858.